Page 1

( Mark One ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON , D.C. 20549 FORM 20 - F 0 REGISTRATION STATEMENT PURSUANT TO SECTION 12 ( b ) OR ( g ) OF THE SECURITIES EXCHANGE ACT OF 1934 OR × ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31 , 2020 OR 0 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to OR 0 SHELL COMPANY PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring this shell company report_ Commission File Number 001-37652 MIDATECH PHARMA PLC ( Exact name of registrant as specified in its charter ) England and Wales ( Jurisdiction of incorporation or organization ) Oddfellows House 19 Newport Road Cardiff , CF24 0AA United Kingdom ( Address of principal executive offices ) Stephen Stamp , Chief Executive Officer and Chief Financial Officer Oddfellows House 19 Newport Road Cardiff , CF24 0AA United Kingdom Tel : +44 1235 888 300 ( Name , Telephone , E - mail and / or Facsimile number and Address of Company Contact Person ) Securities registered or to be registered pursuant to Section 12 ( b ) of the Act . Title of each class Trading Symbol Name of each exchange on which registered Ordinary Shares , nominal value 0.1p each American Depositary Shares , each representing five ordinary shares MTP NASDAQ Capital Market 1